{ "meta": { "tracker_site_url": "https://psilocybin-research.com", "publication_tracker_url": "https://psilocybin-research.com/", "generated_at_utc": "2026-09-12 04:33:10", "record_count": 84, "schema_variant": "rights-safe-core-v1", "text_redistribution": "Source-derived abstracts, descriptions, keywords, and unrestricted payload text are not redistributed." }, "papers": [ { "id": 383, "title": "Effects of Psilocybin on Religious and Spiritual Attitudes and Behaviors in Clergy from Various Major World Religions.", "authors": "Griffiths RR, Jesse R, Richards WA, Johnson MW, Sepeda ND, Bossis AP, Ross S", "journal": "Psychedelic medicine (New Rochelle, N.Y.)", "publication_date": "2025-12-01", "publication_year": 2025, "doi": "10.1089/psymed.2023.0044", "pubmed_id": "41869007", "openalex_id": "https://openalex.org/W4410448036", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41869007/", "substance_tags": "psilocybin", "topic_tags": "Wellbeing,Spirituality,Mystical Experience,Clinical Trial,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:54", "bibtex": null, "source_record_id": "PMID:41869007", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41869007/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41869007", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41869007/", "doi": "10.1089/psymed.2023.0044", "pmid": "41869007", "publication_date": "2025-12-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 793, "title": "A Field-Wide Review and Analysis of Study Materials Used in Psilocybin Trials: Assessment of Two Decades of Research.", "authors": "Yaden DB, Graziosi M, Owen AM, Agin-Liebes G, Aaronson ST, Allen KE, Barrett FS, Bogenschutz MP, Carhart-Harris R, Ching THW, Cosimano MP, Danforth A, Davis AK, Garcia-Romeu A, Griffiths R, Grob CS, Gründer G, Gukasyan N, Heinzerling KG, Hendricks PS, Holze F, Horton DM, Johnson MW, Kelmendi B, Knatz Peck S, Koslowski M, Liechti ME, Mertens LJ, Moreno FA, Nayak SM, Nicholas CR, Preller KH, Rieser NM, Ross S, Sergi K, Sloshower J, Smigielski L, Stenbæk DS, Vollenweider FX, Weiss B, Wolff M, Yaden ME", "journal": "Psychedelic medicine (New Rochelle, N.Y.)", "publication_date": "2025-03-01", "publication_year": 2025, "doi": "10.1089/psymed.2024.0019", "pubmed_id": "40351554", "openalex_id": "https://openalex.org/W4406633420", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40351554/", "substance_tags": "psilocybin", "topic_tags": "Receptor Pharmacology,Consciousness,Wellbeing,Review Article,Safety,Adverse Events,Contraindications", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:01", "bibtex": null, "source_record_id": "PMID:40351554", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40351554/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40351554", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40351554/", "doi": "10.1089/psymed.2024.0019", "pmid": "40351554", "publication_date": "2025-03-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 641, "title": "Psychedelic Experiences Increase Mind Perception but do not Change Atheist-Believer Status: A Prospective Longitudinal Study.", "authors": "Nayak SM, White SH, Hilbert SN, Lowe MX, Jackson H, Griffiths RR, Garcia-Romeu A, Yaden DB", "journal": "Journal of psychoactive drugs", "publication_date": "2025-01-01", "publication_year": 2025, "doi": "10.1080/02791072.2024.2346130", "pubmed_id": "38715376", "openalex_id": "https://openalex.org/W4396728212", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38715376/", "substance_tags": "psilocybin", "topic_tags": "General", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:58", "bibtex": null, "source_record_id": "PMID:38715376", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38715376/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38715376", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38715376/", "doi": "10.1080/02791072.2024.2346130", "pmid": "38715376", "publication_date": "2025-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 968, "title": "Psilocybin-assisted psychotherapy improves psychiatric symptoms across multiple dimensions in patients with cancer.", "authors": "Petridis PD, Grinband J, Agin-Liebes G, Kinslow CJ, Zeifman RJ, Bogenschutz MP, Griffiths RR, Ross S", "journal": "Nature. Mental health", "publication_date": "2024-11-01", "publication_year": 2024, "doi": "10.1038/s44220-024-00331-0", "pubmed_id": "41969367", "openalex_id": "https://openalex.org/W4403196849", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41969367/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Clinical Trial,Cancer Patients", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:06", "bibtex": null, "source_record_id": "PMID:41969367", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41969367/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41969367", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41969367/", "doi": "10.1038/s44220-024-00331-0", "pmid": "41969367", "publication_date": "2024-11-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4596, "title": "Acute Psychedelic Effects and Clinical Outcomes are Associated With Therapeutic Alliance Among Participants Receiving Psilocybin Therapy", "authors": "Alan K. Davis, Adam W. Levin, Rafael Lancelotta, Nathan D. Sepeda, Natalie Gukasyan, Sandeep M. Nayak, Frederick S. Barrett, Roland R. Griffiths", "journal": "Drug and Alcohol Dependence", "publication_date": "2024-07-01", "publication_year": 2024, "doi": "10.1016/j.drugalcdep.2023.110609", "pubmed_id": null, "openalex_id": "https://openalex.org/W4400575216", "source_url": "https://doi.org/10.1016/j.drugalcdep.2023.110609", "substance_tags": "psilocybin", "topic_tags": "Anxiety", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:43", "last_checked": "2026-08-09 08:25:28", "bibtex": null, "source_record_id": "DOI:10.1016/j.drugalcdep.2023.110609", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.drugalcdep.2023.110609", "source_url": "https://doi.org/10.1016/j.drugalcdep.2023.110609", "doi": "10.1016/j.drugalcdep.2023.110609", "pmid": "", "publication_date": "2024-07-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4592, "title": "Associations Between Harm Reduction Strategy Use and Acute Psychedelic Effects in Spanish Speakers who Used LSD or Psilocybin", "authors": "Rafael Lancelotta, Christopher Timmerman, Ana María Ortiz Bernal, Sandeep M. Nayak, Nathan D. Sepeda, Aki Nikolaidis, Roland R. Griffiths, Alan K. Davis", "journal": "Drug and Alcohol Dependence", "publication_date": "2024-07-01", "publication_year": 2024, "doi": "10.1016/j.drugalcdep.2023.110861", "pubmed_id": null, "openalex_id": "https://openalex.org/W4400574241", "source_url": "https://doi.org/10.1016/j.drugalcdep.2023.110861", "substance_tags": "psilocybin", "topic_tags": "Toxicity", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:43", "last_checked": "2026-08-09 08:25:28", "bibtex": null, "source_record_id": "DOI:10.1016/j.drugalcdep.2023.110861", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.drugalcdep.2023.110861", "source_url": "https://doi.org/10.1016/j.drugalcdep.2023.110861", "doi": "10.1016/j.drugalcdep.2023.110861", "pmid": "", "publication_date": "2024-07-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1105, "title": "Impact of Psilocybin on Peripheral Cytokine Production.", "authors": "DiRenzo D, Barrett FS, Perin J, Darrah E, Christopher-Stine L, Griffiths RR", "journal": "Psychedelic medicine (New Rochelle, N.Y.)", "publication_date": "2024-06-01", "publication_year": 2024, "doi": "10.1089/psymed.2023.0039", "pubmed_id": "40051582", "openalex_id": "https://openalex.org/W4392242985", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40051582/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Clinical Trial,Randomized Controlled Trial,Inflammation,Immune Function", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:08", "bibtex": null, "source_record_id": "PMID:40051582", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40051582/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40051582", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40051582/", "doi": "10.1089/psymed.2023.0039", "pmid": "40051582", "publication_date": "2024-06-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1199, "title": "The therapeutic alliance between study participants and intervention facilitators is associated with acute effects and clinical outcomes in a psilocybin-assisted therapy trial for major depressive disorder.", "authors": "Levin AW, Lancelotta R, Sepeda ND, Gukasyan N, Nayak S, Wagener TL, Barrett FS, Griffiths RR, Davis AK", "journal": "PloS one", "publication_date": "2024-01-01", "publication_year": 2024, "doi": "10.1371/journal.pone.0300501", "pubmed_id": "38483940", "openalex_id": "https://openalex.org/W4392797453", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38483940/", "substance_tags": "psilocybin", "topic_tags": "Depression,Mystical Experience,Clinical Trial", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:10", "bibtex": null, "source_record_id": "PMID:38483940", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38483940/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38483940", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38483940/", "doi": "10.1371/journal.pone.0300501", "pmid": "38483940", "publication_date": "2024-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1045, "title": "Translation and Initial Psychometric Evaluation of Spanish Versions of Three Psychedelic Acute Effects Measures: Mystical, Challenging, and Insight Experiences.", "authors": "Davis AK, Timmermann C, Ortiz Bernal AM, Lancelotta R, Nayak S, Sepeda ND, Nikolaidis A, Griffiths RR", "journal": "Journal of psychoactive drugs", "publication_date": "2024-01-01", "publication_year": 2024, "doi": "10.1080/02791072.2023.2232379", "pubmed_id": "37449499", "openalex_id": "https://openalex.org/W4384339800", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37449499/", "substance_tags": "psilocybin", "topic_tags": "Mystical Experience,Observational Study", "study_type": "Observational Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:07", "bibtex": null, "source_record_id": "PMID:37449499", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37449499/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37449499", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37449499/", "doi": "10.1080/02791072.2023.2232379", "pmid": "37449499", "publication_date": "2024-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1315, "title": "Double-Blind Comparison of the Two Hallucinogens Dextromethorphan and Psilocybin: Experience-Dependent and Enduring Psychological Effects in Healthy Volunteers.", "authors": "Mathai DS, Hilbert S, Sepeda ND, Strickland JC, Griffiths RR, Garcia-Romeu A", "journal": "Psychedelic medicine (New Rochelle, N.Y.)", "publication_date": "2023-12-01", "publication_year": 2023, "doi": "10.1089/psymed.2023.0035", "pubmed_id": "38152462", "openalex_id": "https://openalex.org/W4386285211", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38152462/", "substance_tags": "psilocybin", "topic_tags": "Receptor Pharmacology,Consciousness,Wellbeing,Spirituality,Healthy Volunteers,Safety", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:11", "bibtex": null, "source_record_id": "PMID:38152462", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38152462/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38152462", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38152462/", "doi": "10.1089/psymed.2023.0035", "pmid": "38152462", "publication_date": "2023-12-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1379, "title": "Single-Dose Psilocybin Treatment for Major Depressive Disorder: A Randomized Clinical Trial.", "authors": "Raison CL, Sanacora G, Woolley J, Heinzerling K, Dunlop BW, Brown RT, Kakar R, Hassman M, Trivedi RP, Robison R, Gukasyan N, Nayak SM, Hu X, O'Donnell KC, Kelmendi B, Sloshower J, Penn AD, Bradley E, Kelly DF, Mletzko T, Nicholas CR, Hutson PR, Tarpley G, Utzinger M, Lenoch K, Warchol K, Gapasin T, Davis MC, Nelson-Douthit C, Wilson S, Brown C, Linton W, Ross S, Griffiths RR", "journal": "JAMA", "publication_date": "2023-09-05", "publication_year": 2023, "doi": "10.1001/jama.2023.14530", "pubmed_id": "37651119", "openalex_id": "https://openalex.org/W4386305655", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37651119/", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Clinical Trial,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:12", "bibtex": null, "source_record_id": "PMID:37651119", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37651119/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37651119", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37651119/", "doi": "10.1001/jama.2023.14530", "pmid": "37651119", "publication_date": "2023-09-05", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1390, "title": "Assessing the risk of symptom worsening in psilocybin-assisted therapy for depression: A systematic review and individual participant data meta-analysis.", "authors": "Simonsson O, Carlbring P, Carhart-Harris R, Davis AK, Nutt DJ, Griffiths RR, Erritzoe D, Goldberg SB", "journal": "Psychiatry research", "publication_date": "2023-09-01", "publication_year": 2023, "doi": "10.1016/j.psychres.2023.115349", "pubmed_id": "37523886", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/37523886/", "substance_tags": "psilocybin", "topic_tags": "Depression,Meta-Analysis,Systematic Review,Review Article,Safety", "study_type": "Meta-Analysis", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:13", "bibtex": null, "source_record_id": "PMID:37523886", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37523886/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37523886", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37523886/", "doi": "10.1016/j.psychres.2023.115349", "pmid": "37523886", "publication_date": "2023-09-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1447, "title": "Corrigendum to 'Psilocybin induces spatially constrained alterations in thalamic functional organizaton and connectivity': Neuroimage 2022 Oct 15;260:119434.", "authors": "Gaddis A, Lidstone DE, Nebel MB, Griffiths RR, Mostofsky SH, Mejia AF, Barrett FS", "journal": "NeuroImage", "publication_date": "2023-07-01", "publication_year": 2023, "doi": "10.1016/j.neuroimage.2023.120130", "pubmed_id": "37148779", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/37148779/", "substance_tags": "psilocybin", "topic_tags": "General", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:15", "bibtex": null, "source_record_id": "PMID:37148779", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37148779", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37148779/", "doi": "10.1016/j.neuroimage.2023.120130", "pmid": "37148779", "publication_date": "2023-07-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1443, "title": "Attenuation of psilocybin mushroom effects during and after SSRI/SNRI antidepressant use.", "authors": "Gukasyan N, Griffiths RR, Yaden DB, Antoine DG, Nayak SM", "journal": "Journal of psychopharmacology (Oxford, England)", "publication_date": "2023-07-01", "publication_year": 2023, "doi": "10.1177/02698811231179910", "pubmed_id": "37291890", "openalex_id": "https://openalex.org/W4379967727", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37291890/", "substance_tags": "psilocybin", "topic_tags": "Depression,Receptor Pharmacology,Observational Study,Drug Interactions", "study_type": "Observational Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:14", "bibtex": null, "source_record_id": "PMID:37291890", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37291890/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37291890", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37291890/", "doi": "10.1177/02698811231179910", "pmid": "37291890", "publication_date": "2023-07-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3793, "title": "Naturalistic Psilocybin Use Increases Mind Perception but not Atheist-Believer status: A Prospective Longitudinal Study", "authors": "Nayak SM, White S, Hilbert S, Lowe MX, Jackson H, Griffiths RR, Garcia-Romeu A, Yaden DB.", "journal": "PsyArXiv", "publication_date": "2023-06-09", "publication_year": 2023, "doi": "10.31234/osf.io/auycp", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.31234/osf.io/auycp", "substance_tags": "psilocybin", "topic_tags": "General", "study_type": "Other", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:10:22", "last_checked": "2026-08-09 08:15:27", "bibtex": null, "source_record_id": "DOI:10.31234/osf.io/auycp", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://doi.org/10.31234/osf.io/auycp", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.31234/osf.io/auycp", "source_url": "https://doi.org/10.31234/osf.io/auycp", "doi": "10.31234/osf.io/auycp", "pmid": "", "publication_date": "2023-06-09", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3359, "title": "Naturalistic Psilocybin Use Increases Mind Perception but not Atheist-Believer status: A Prospective Longitudinal Study", "authors": "Nayak SM, White SH, Hilbert S, Lowe MX, Jackson H, Griffiths RR, Garcia-Romeu A, Yaden DB.", "journal": "PsyArXiv", "publication_date": "2023-06-09", "publication_year": 2023, "doi": "10.31234/osf.io/auycp_v1", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.31234/osf.io/auycp_v1", "substance_tags": "psilocybin", "topic_tags": "General", "study_type": "Other", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:51", "last_checked": "2026-08-09 08:15:27", "bibtex": null, "source_record_id": "DOI:10.31234/osf.io/auycp_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://doi.org/10.31234/osf.io/auycp_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.31234/osf.io/auycp_v1", "source_url": "https://doi.org/10.31234/osf.io/auycp_v1", "doi": "10.31234/osf.io/auycp_v1", "pmid": "", "publication_date": "2023-06-09", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3358, "title": "Naturalistic Psilocybin Use Increases Mind Perception but not Atheist-Believer status: A Prospective Longitudinal Study", "authors": "Sandeep M Nayak, Sydney White, Samantha Hilbert, Matthew X Lowe, Heather Jackson, Roland R. Griffiths, Albert Garcia-Romeu, David Bryce Yaden", "journal": "PsyArXiv", "publication_date": "2023-06-09", "publication_year": 2023, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/auycp_v1", "substance_tags": "psilocybin", "topic_tags": "General", "study_type": "Other", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:51", "last_checked": "2026-08-09 08:20:21", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/auycp_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/auycp_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/auycp_v1", "source_url": "https://osf.io/preprints/psyarxiv/auycp_v1", "doi": "", "pmid": "", "publication_date": "2023-06-09", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1372, "title": "Naturalistic psilocybin use is associated with persisting improvements in mental health and wellbeing: results from a prospective, longitudinal survey.", "authors": "Nayak SM, Jackson H, Sepeda ND, Mathai DS, So S, Yaffe A, Zaki H, Brasher TJ, Lowe MX, Jolly DRP, Barrett FS, Griffiths RR, Strickland JC, Johnson MW, Jackson H, Garcia-Romeu A", "journal": "Frontiers in psychiatry", "publication_date": "2023-01-01", "publication_year": 2023, "doi": "10.3389/fpsyt.2023.1199642", "pubmed_id": "37795509", "openalex_id": "https://openalex.org/W4386861633", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37795509/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Wellbeing,Emotional Processing,Spirituality,Mystical Experience,Observational Study", "study_type": "Observational Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:12", "bibtex": null, "source_record_id": "PMID:37795509", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37795509/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37795509", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37795509/", "doi": "10.3389/fpsyt.2023.1199642", "pmid": "37795509", "publication_date": "2023-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1627, "title": "Psychedelic-Assisted Therapy for People with Eating Disorders.", "authors": "Gukasyan N, Schreyer CC, Griffiths RR, Guarda AS", "journal": "Current psychiatry reports", "publication_date": "2022-12-01", "publication_year": 2022, "doi": "10.1007/s11920-022-01394-5", "pubmed_id": "36374357", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/36374357/", "substance_tags": "psilocybin", "topic_tags": "Eating Disorders,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:18", "bibtex": null, "source_record_id": "PMID:36374357", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/36374357/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:36374357", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36374357/", "doi": "10.1007/s11920-022-01394-5", "pmid": "36374357", "publication_date": "2022-12-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1650, "title": "Psychedelic drug abuse potential assessment research for new drug applications and Controlled Substances Act scheduling.", "authors": "Henningfield JE, Coe MA, Griffiths RR, Belouin SJ, Berger A, Coker AR, Comer SD, Heal DJ, Hendricks PS, Nichols CD, Sapienza F, Vocci FJ, Zia FZ", "journal": "Neuropharmacology", "publication_date": "2022-11-01", "publication_year": 2022, "doi": "10.1016/j.neuropharm.2022.109220", "pubmed_id": "35987353", "openalex_id": "https://openalex.org/W4292136326", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35987353/", "substance_tags": "psilocybin", "topic_tags": "Mechanism of Action,Consciousness,Spirituality,Safety,Abuse Liability", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:18", "bibtex": null, "source_record_id": "PMID:35987353", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/35987353/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35987353", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35987353/", "doi": "10.1016/j.neuropharm.2022.109220", "pmid": "35987353", "publication_date": "2022-11-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3756, "title": "Serotonergic antidepressant use is associated with weaker psilocybin effects", "authors": "Gukasyan N, Griffiths RR, Yaden DB, Antoine D, Nayak SM.", "journal": "PsyArXiv", "publication_date": "2022-10-28", "publication_year": 2022, "doi": "10.31234/osf.io/2zys9", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.31234/osf.io/2zys9", "substance_tags": "psilocybin", "topic_tags": "Depression,Observational Study", "study_type": "Observational Study", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:10:19", "last_checked": "2026-08-09 08:15:07", "bibtex": null, "source_record_id": "DOI:10.31234/osf.io/2zys9", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://doi.org/10.31234/osf.io/2zys9", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.31234/osf.io/2zys9", "source_url": "https://doi.org/10.31234/osf.io/2zys9", "doi": "10.31234/osf.io/2zys9", "pmid": "", "publication_date": "2022-10-28", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3170, "title": "Serotonergic antidepressant use is associated with weaker psilocybin effects", "authors": "Natalie Gukasyan, Roland R. Griffiths, David Bryce Yaden, Denis Antoine, Sandeep M Nayak", "journal": "PsyArXiv", "publication_date": "2022-10-28", "publication_year": 2022, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/2zys9_v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Receptor Pharmacology,Observational Study,Drug Interactions", "study_type": "Observational Study", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:47", "last_checked": "2026-08-09 08:20:21", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/2zys9_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/2zys9_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/2zys9_v1", "source_url": "https://osf.io/preprints/psyarxiv/2zys9_v1", "doi": "", "pmid": "", "publication_date": "2022-10-28", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1658, "title": "Psilocybin induces spatially constrained alterations in thalamic functional organizaton and connectivity.", "authors": "Gaddis A, Lidstone DE, Nebel MB, Griffiths RR, Mostofsky SH, Mejia AF, Barrett FS", "journal": "NeuroImage", "publication_date": "2022-10-15", "publication_year": 2022, "doi": "10.1016/j.neuroimage.2022.119434", "pubmed_id": "35792293", "openalex_id": "https://openalex.org/W4283768889", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35792293/", "substance_tags": "psilocybin", "topic_tags": "Brain Imaging,Receptor Pharmacology,Default Mode Network", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:18", "bibtex": null, "source_record_id": "PMID:35792293", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/35792293/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35792293", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35792293/", "doi": "10.1016/j.neuroimage.2022.119434", "pmid": "35792293", "publication_date": "2022-10-15", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3398, "title": "Unique Effects of Sedatives, Dissociatives, Psychedelics, Stimulants, and Cannabinoids on Episodic Memory: A Review and Reanalysis of Acute Drug Effects on Recollection, Familiarity, and Metamemory", "authors": "Doss MK, Samaha J, Barrett FS, Griffiths RR, de Wit H, Gallo DA, Koen JD.", "journal": "bioRxiv", "publication_date": "2022-05-24", "publication_year": 2022, "doi": "10.1101/2022.05.20.492842", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.1101/2022.05.20.492842", "substance_tags": "psilocybin", "topic_tags": "Pharmacology,Mechanism of Action,Consciousness,Systematic Review,Review Article", "study_type": "Systematic Review", "source_name": "bioRxiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:52", "last_checked": "2026-08-09 08:15:32", "bibtex": null, "source_record_id": "DOI:10.1101/2022.05.20.492842", "abstract_available": true, "abstract_source": "bioRxiv", "abstract_source_url": "https://doi.org/10.1101/2022.05.20.492842", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "bioRxiv", "source_record_id": "DOI:10.1101/2022.05.20.492842", "source_url": "https://doi.org/10.1101/2022.05.20.492842", "doi": "10.1101/2022.05.20.492842", "pmid": "", "publication_date": "2022-05-24", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1794, "title": "Models of psychedelic drug action: modulation of cortical-subcortical circuits.", "authors": "Doss MK, Madden MB, Gaddis A, Nebel MB, Griffiths RR, Mathur BN, Barrett FS", "journal": "Brain: a journal of neurology", "publication_date": "2022-04-18", "publication_year": 2022, "doi": "10.1093/brain/awab406", "pubmed_id": "34897383", "openalex_id": "https://openalex.org/W4200471428", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34897383/", "substance_tags": "psilocybin", "topic_tags": "Receptor Pharmacology,Default Mode Network", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:20", "bibtex": null, "source_record_id": "PMID:34897383", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/34897383/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:34897383", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34897383/", "doi": "10.1093/brain/awab406", "pmid": "34897383", "publication_date": "2022-04-18", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3226, "title": "Psilocybin induces spatially constrained alterations in thalamic functional organizaton and connectivity", "authors": "Gaddis A, Lidstone DE, Nebel MB, Griffiths R, Mostofsky SH, Mejia A, Barrett F.", "journal": "bioRxiv", "publication_date": "2022-03-02", "publication_year": 2022, "doi": "10.1101/2022.02.28.482395", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.1101/2022.02.28.482395", "substance_tags": "psilocybin", "topic_tags": "Brain Imaging,Receptor Pharmacology,Default Mode Network", "study_type": "Other", "source_name": "bioRxiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:48", "last_checked": "2026-08-09 08:15:12", "bibtex": null, "source_record_id": "DOI:10.1101/2022.02.28.482395", "abstract_available": true, "abstract_source": "bioRxiv", "abstract_source_url": "https://doi.org/10.1101/2022.02.28.482395", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "bioRxiv", "source_record_id": "DOI:10.1101/2022.02.28.482395", "source_url": "https://doi.org/10.1101/2022.02.28.482395", "doi": "10.1101/2022.02.28.482395", "pmid": "", "publication_date": "2022-03-02", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1827, "title": "Efficacy and safety of psilocybin-assisted treatment for major depressive disorder: Prospective 12-month follow-up.", "authors": "Gukasyan N, Davis AK, Barrett FS, Cosimano MP, Sepeda ND, Johnson MW, Griffiths RR", "journal": "Journal of psychopharmacology (Oxford, England)", "publication_date": "2022-02-01", "publication_year": 2022, "doi": "10.1177/02698811211073759", "pubmed_id": "35166158", "openalex_id": "https://openalex.org/W4212903385", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35166158/", "substance_tags": "psilocybin", "topic_tags": "Depression,Wellbeing,Spirituality,Mystical Experience,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:21", "bibtex": null, "source_record_id": "PMID:35166158", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/35166158/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35166158", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35166158/", "doi": "10.1177/02698811211073759", "pmid": "35166158", "publication_date": "2022-02-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1851, "title": "The Potential of Psychedelics for End of Life and Palliative Care.", "authors": "Yaden DB, Nayak SM, Gukasyan N, Anderson BT, Griffiths RR", "journal": "Current topics in behavioral neurosciences", "publication_date": "2022-01-01", "publication_year": 2022, "doi": "10.1007/7854_2021_278", "pubmed_id": "34958455", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/34958455/", "substance_tags": "psilocybin", "topic_tags": "Depression,End-of-Life Distress,Wellbeing,Review Article,Healthcare Workers", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:21", "bibtex": null, "source_record_id": "PMID:34958455", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/34958455/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:34958455", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34958455/", "doi": "10.1007/7854_2021_278", "pmid": "34958455", "publication_date": "2022-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1710, "title": "Comparison of psychedelic and near-death or other non-ordinary experiences in changing attitudes about death and dying.", "authors": "Sweeney MM, Nayak S, Hurwitz ES, Mitchell LN, Swift TC, Griffiths RR", "journal": "PloS one", "publication_date": "2022-01-01", "publication_year": 2022, "doi": "10.1371/journal.pone.0271926", "pubmed_id": "36001643", "openalex_id": "https://openalex.org/W4293101934", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36001643/", "substance_tags": "psilocybin", "topic_tags": "Spirituality,Mystical Experience,Observational Study", "study_type": "Observational Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:19", "bibtex": null, "source_record_id": "PMID:36001643", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/36001643/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:36001643", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36001643/", "doi": "10.1371/journal.pone.0271926", "pmid": "36001643", "publication_date": "2022-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1888, "title": "Psilocybin therapy increases cognitive and neural flexibility in patients with major depressive disorder.", "authors": "Doss MK, Považan M, Rosenberg MD, Sepeda ND, Davis AK, Finan PH, Smith GS, Pekar JJ, Barker PB, Griffiths RR, Barrett FS", "journal": "Translational psychiatry", "publication_date": "2021-11-08", "publication_year": 2021, "doi": "10.1038/s41398-021-01706-y", "pubmed_id": "34750350", "openalex_id": "https://openalex.org/W3213458191", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34750350/", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Mechanism of Action,Aging", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:06", "last_checked": "2026-08-09 08:28:21", "bibtex": null, "source_record_id": "PMID:34750350", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/34750350/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:34750350", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34750350/", "doi": "10.1038/s41398-021-01706-y", "pmid": "34750350", "publication_date": "2021-11-08", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1911, "title": "Classic Psychedelic Coadministration with Lithium, but Not Lamotrigine, is Associated with Seizures: An Analysis of Online Psychedelic Experience Reports.", "authors": "Nayak SM, Gukasyan N, Barrett FS, Erowid E, Erowid F, Griffiths RR", "journal": "Pharmacopsychiatry", "publication_date": "2021-09-01", "publication_year": 2021, "doi": "10.1055/a-1524-2794", "pubmed_id": "34348413", "openalex_id": "https://openalex.org/W3160183306", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34348413/", "substance_tags": "psilocybin", "topic_tags": "Depression,Safety", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:06", "last_checked": "2026-08-09 08:28:22", "bibtex": null, "source_record_id": "PMID:34348413", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/34348413/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:34348413", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34348413/", "doi": "10.1055/a-1524-2794", "pmid": "34348413", "publication_date": "2021-09-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2128, "title": "Psychedelics and Consciousness: Distinctions, Demarcations, and Opportunities.", "authors": "Yaden DB, Johnson MW, Griffiths RR, Doss MK, Garcia-Romeu A, Nayak S, Gukasyan N, Mathur BN, Barrett FS", "journal": "The international journal of neuropsychopharmacology", "publication_date": "2021-08-20", "publication_year": 2021, "doi": "10.1093/ijnp/pyab026", "pubmed_id": "33987652", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/33987652/", "substance_tags": "psilocybin", "topic_tags": "Consciousness,Review Article", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:22", "bibtex": null, "source_record_id": "PMID:33987652", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/33987652/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:33987652", "source_url": "https://pubmed.ncbi.nlm.nih.gov/33987652/", "doi": "10.1093/ijnp/pyab026", "pmid": "33987652", "publication_date": "2021-08-20", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2160, "title": "Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder: A Randomized Clinical Trial.", "authors": "Davis AK, Barrett FS, May DG, Cosimano MP, Sepeda ND, Johnson MW, Finan PH, Griffiths RR", "journal": "JAMA psychiatry", "publication_date": "2021-05-01", "publication_year": 2021, "doi": "10.1001/jamapsychiatry.2020.3285", "pubmed_id": "33146667", "openalex_id": "https://openalex.org/W3096208965", "source_url": "https://pubmed.ncbi.nlm.nih.gov/33146667/", "substance_tags": "psilocybin", "topic_tags": "Depression,Consciousness,Clinical Trial,Treatment-Resistant Depression", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:22", "bibtex": null, "source_record_id": "PMID:33146667", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/33146667/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:33146667", "source_url": "https://pubmed.ncbi.nlm.nih.gov/33146667/", "doi": "10.1001/jamapsychiatry.2020.3285", "pmid": "33146667", "publication_date": "2021-05-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2158, "title": "Errors in a Response Rate and in Effect Sizes in Study of Psilocybin-Assisted Therapy for Major Depressive Disorder.", "authors": "Davis AK, Griffiths RR", "journal": "JAMA psychiatry", "publication_date": "2021-05-01", "publication_year": 2021, "doi": "10.1001/jamapsychiatry.2020.4638", "pubmed_id": "33566073", "openalex_id": "https://openalex.org/W3128054002", "source_url": "https://pubmed.ncbi.nlm.nih.gov/33566073/", "substance_tags": "psilocybin", "topic_tags": "Depression", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:22", "bibtex": null, "source_record_id": "PMID:33566073", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:33566073", "source_url": "https://pubmed.ncbi.nlm.nih.gov/33566073/", "doi": "10.1001/jamapsychiatry.2020.4638", "pmid": "33566073", "publication_date": "2021-05-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2182, "title": "Development of the Psychological Insight Questionnaire among a sample of people who have consumed psilocybin or LSD.", "authors": "Davis AK, Barrett FS, So S, Gukasyan N, Swift TC, Griffiths RR", "journal": "Journal of psychopharmacology (Oxford, England)", "publication_date": "2021-04-01", "publication_year": 2021, "doi": "10.1177/0269881120967878", "pubmed_id": "33427007", "openalex_id": "https://openalex.org/W3118498264", "source_url": "https://pubmed.ncbi.nlm.nih.gov/33427007/", "substance_tags": "psilocybin", "topic_tags": "Wellbeing,Mystical Experience,Psychological Flexibility,Observational Study", "study_type": "Observational Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:23", "bibtex": null, "source_record_id": "PMID:33427007", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/33427007/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:33427007", "source_url": "https://pubmed.ncbi.nlm.nih.gov/33427007/", "doi": "10.1177/0269881120967878", "pmid": "33427007", "publication_date": "2021-04-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2179, "title": "Optimal dosing for psilocybin pharmacotherapy: Considering weight-adjusted and fixed dosing approaches.", "authors": "Garcia-Romeu A, Barrett FS, Carbonaro TM, Johnson MW, Griffiths RR", "journal": "Journal of psychopharmacology (Oxford, England)", "publication_date": "2021-04-01", "publication_year": 2021, "doi": "10.1177/0269881121991822", "pubmed_id": "33611977", "openalex_id": "https://openalex.org/W3129221857", "source_url": "https://pubmed.ncbi.nlm.nih.gov/33611977/", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Receptor Pharmacology,Mystical Experience", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:23", "bibtex": null, "source_record_id": "PMID:33611977", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/33611977/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:33611977", "source_url": "https://pubmed.ncbi.nlm.nih.gov/33611977/", "doi": "10.1177/0269881121991822", "pmid": "33611977", "publication_date": "2021-04-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3370, "title": "Classic psychedelic coadministration with lithium, but not lamotrigine, is associated with seizures: an analysis of online psychedelic experience reports", "authors": "Nayak S, Gukasyan N, Barrett FS, Erowid E, Erowid F, Griffiths RR.", "journal": "PsyArXiv", "publication_date": "2021-02-24", "publication_year": 2021, "doi": "10.31234/osf.io/r726d", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.31234/osf.io/r726d", "substance_tags": "psilocybin", "topic_tags": "Depression,Safety", "study_type": "Other", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:51", "last_checked": "2026-08-09 08:15:28", "bibtex": null, "source_record_id": "DOI:10.31234/osf.io/r726d", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://doi.org/10.31234/osf.io/r726d", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.31234/osf.io/r726d", "source_url": "https://doi.org/10.31234/osf.io/r726d", "doi": "10.31234/osf.io/r726d", "pmid": "", "publication_date": "2021-02-24", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1916, "title": "Trends in the Top-Cited Articles on Classic Psychedelics.", "authors": "Lawrence DW, Sharma B, Griffiths RR, Carhart-Harris R", "journal": "Journal of psychoactive drugs", "publication_date": "2021-01-01", "publication_year": 2021, "doi": "10.1080/02791072.2021.1874573", "pubmed_id": "33535907", "openalex_id": "https://openalex.org/W3127644232", "source_url": "https://pubmed.ncbi.nlm.nih.gov/33535907/", "substance_tags": "psilocybin", "topic_tags": "Addiction,Observational Study,Animal Study", "study_type": "Observational Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:06", "last_checked": "2026-08-09 08:28:22", "bibtex": null, "source_record_id": "PMID:33535907", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/33535907/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:33535907", "source_url": "https://pubmed.ncbi.nlm.nih.gov/33535907/", "doi": "10.1080/02791072.2021.1874573", "pmid": "33535907", "publication_date": "2021-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1833, "title": "Human Cortical Serotonin 2A Receptor Occupancy by Psilocybin Measured Using [C]MDL100,907 Dynamic PET and a Resting-State fMRI-Based Brain Parcellation.", "authors": "Barrett FS, Zhou Y, Carbonaro TM, Roberts JM, Smith GS, Griffiths RR, Wong DF", "journal": "Frontiers in neuroergonomics", "publication_date": "2021-01-01", "publication_year": 2021, "doi": "10.3389/fnrgo.2021.784576", "pubmed_id": "38235248", "openalex_id": "https://openalex.org/W4206591786", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38235248/", "substance_tags": "psilocybin", "topic_tags": "Addiction,Brain Imaging,Pharmacology,Receptor Pharmacology,Default Mode Network,Healthy Volunteers", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:21", "bibtex": null, "source_record_id": "PMID:38235248", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38235248/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38235248", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38235248/", "doi": "10.3389/fnrgo.2021.784576", "pmid": "38235248", "publication_date": "2021-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2255, "title": "Psilocybin acutely alters the functional connectivity of the claustrum with brain networks that support perception, memory, and attention.", "authors": "Barrett FS, Krimmel SR, Griffiths RR, Seminowicz DA, Mathur BN", "journal": "NeuroImage", "publication_date": "2020-09-01", "publication_year": 2020, "doi": "10.1016/j.neuroimage.2020.116980", "pubmed_id": "32454209", "openalex_id": "https://openalex.org/W3027721867", "source_url": "https://pubmed.ncbi.nlm.nih.gov/32454209/", "substance_tags": "psilocybin", "topic_tags": "Brain Imaging,Mechanism of Action,Receptor Pharmacology,Default Mode Network,Healthy Volunteers", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:24", "bibtex": null, "source_record_id": "PMID:32454209", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/32454209/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:32454209", "source_url": "https://pubmed.ncbi.nlm.nih.gov/32454209/", "doi": "10.1016/j.neuroimage.2020.116980", "pmid": "32454209", "publication_date": "2020-09-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2261, "title": "Subjective features of the psilocybin experience that may account for its self-administration by humans: a double-blind comparison of psilocybin and dextromethorphan.", "authors": "Carbonaro TM, Johnson MW, Griffiths RR", "journal": "Psychopharmacology", "publication_date": "2020-08-01", "publication_year": 2020, "doi": "10.1007/s00213-020-05533-9", "pubmed_id": "32500212", "openalex_id": "https://openalex.org/W3033752070", "source_url": "https://pubmed.ncbi.nlm.nih.gov/32500212/", "substance_tags": "psilocybin", "topic_tags": "Mystical Experience,Healthy Volunteers,Abuse Liability", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:24", "bibtex": null, "source_record_id": "PMID:32500212", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/32500212/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:32500212", "source_url": "https://pubmed.ncbi.nlm.nih.gov/32500212/", "doi": "10.1007/s00213-020-05533-9", "pmid": "32500212", "publication_date": "2020-08-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2298, "title": "Emotions and brain function are altered up to one month after a single high dose of psilocybin.", "authors": "Barrett FS, Doss MK, Sepeda ND, Pekar JJ, Griffiths RR", "journal": "Scientific reports", "publication_date": "2020-02-10", "publication_year": 2020, "doi": "10.1038/s41598-020-59282-y", "pubmed_id": "32042038", "openalex_id": "https://openalex.org/W3005441929", "source_url": "https://pubmed.ncbi.nlm.nih.gov/32042038/", "substance_tags": "psilocybin", "topic_tags": "Anxiety,Addiction,Neuroplasticity,Emotional Processing,Healthy Volunteers", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:24", "bibtex": null, "source_record_id": "PMID:32042038", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/32042038/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:32042038", "source_url": "https://pubmed.ncbi.nlm.nih.gov/32042038/", "doi": "10.1038/s41598-020-59282-y", "pmid": "32042038", "publication_date": "2020-02-10", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2332, "title": "Cessation and reduction in alcohol consumption and misuse after psychedelic use.", "authors": "Garcia-Romeu A, Davis AK, Erowid F, Erowid E, Griffiths RR, Johnson MW", "journal": "Journal of psychopharmacology (Oxford, England)", "publication_date": "2019-09-01", "publication_year": 2019, "doi": "10.1177/0269881119845793", "pubmed_id": "31084460", "openalex_id": "https://openalex.org/W2945506353", "source_url": "https://pubmed.ncbi.nlm.nih.gov/31084460/", "substance_tags": "psilocybin", "topic_tags": "Addiction,Mystical Experience,Meta-Analysis,Observational Study", "study_type": "Meta-Analysis", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:25", "bibtex": null, "source_record_id": "PMID:31084460", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/31084460/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:31084460", "source_url": "https://pubmed.ncbi.nlm.nih.gov/31084460/", "doi": "10.1177/0269881119845793", "pmid": "31084460", "publication_date": "2019-09-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2347, "title": "Classic psychedelics: An integrative review of epidemiology, therapeutics, mystical experience, and brain network function.", "authors": "Johnson MW, Hendricks PS, Barrett FS, Griffiths RR", "journal": "Pharmacology & therapeutics", "publication_date": "2019-05-01", "publication_year": 2019, "doi": "10.1016/j.pharmthera.2018.11.010", "pubmed_id": "30521880", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/30521880/", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,End-of-Life Distress,Brain Imaging,Mechanism of Action,Receptor Pharmacology,Consciousness,Aging,Mystical Experience,Review Article,Healthy Volunteers", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:25", "bibtex": null, "source_record_id": "PMID:30521880", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/30521880/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:30521880", "source_url": "https://pubmed.ncbi.nlm.nih.gov/30521880/", "doi": "10.1016/j.pharmthera.2018.11.010", "pmid": "30521880", "publication_date": "2019-05-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2349, "title": "Survey of subjective \"God encounter experiences\": Comparisons among naturally occurring experiences and those occasioned by the classic psychedelics psilocybin, LSD, ayahuasca, or DMT.", "authors": "Griffiths RR, Hurwitz ES, Davis AK, Johnson MW, Jesse R", "journal": "PloS one", "publication_date": "2019-01-01", "publication_year": 2019, "doi": "10.1371/journal.pone.0214377", "pubmed_id": "31013281", "openalex_id": "https://openalex.org/W2940999002", "source_url": "https://pubmed.ncbi.nlm.nih.gov/31013281/", "substance_tags": "psilocybin", "topic_tags": "Spirituality,Mystical Experience,Observational Study", "study_type": "Observational Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:25", "bibtex": null, "source_record_id": "PMID:31013281", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/31013281/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:31013281", "source_url": "https://pubmed.ncbi.nlm.nih.gov/31013281/", "doi": "10.1371/journal.pone.0214377", "pmid": "31013281", "publication_date": "2019-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2303, "title": "Persisting Reductions in Cannabis, Opioid, and Stimulant Misuse After Naturalistic Psychedelic Use: An Online Survey.", "authors": "Garcia-Romeu A, Davis AK, Erowid E, Erowid F, Griffiths RR, Johnson MW", "journal": "Frontiers in psychiatry", "publication_date": "2019-01-01", "publication_year": 2019, "doi": "10.3389/fpsyt.2019.00955", "pubmed_id": "32038317", "openalex_id": "https://openalex.org/W3001327571", "source_url": "https://pubmed.ncbi.nlm.nih.gov/32038317/", "substance_tags": "psilocybin", "topic_tags": "Addiction,Receptor Pharmacology,Mystical Experience,Observational Study", "study_type": "Observational Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:24", "bibtex": null, "source_record_id": "PMID:32038317", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/32038317/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:32038317", "source_url": "https://pubmed.ncbi.nlm.nih.gov/32038317/", "doi": "10.3389/fpsyt.2019.00955", "pmid": "32038317", "publication_date": "2019-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2375, "title": "The abuse potential of medical psilocybin according to the 8 factors of the Controlled Substances Act.", "authors": "Johnson MW, Griffiths RR, Hendricks PS, Henningfield JE", "journal": "Neuropharmacology", "publication_date": "2018-11-01", "publication_year": 2018, "doi": "10.1016/j.neuropharm.2018.05.012", "pubmed_id": "29753748", "openalex_id": "https://openalex.org/W2806419184", "source_url": "https://pubmed.ncbi.nlm.nih.gov/29753748/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Receptor Pharmacology,Review Article,Cancer Patients,Safety", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:25", "bibtex": null, "source_record_id": "PMID:29753748", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/29753748/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:29753748", "source_url": "https://pubmed.ncbi.nlm.nih.gov/29753748/", "doi": "10.1016/j.neuropharm.2018.05.012", "pmid": "29753748", "publication_date": "2018-11-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2386, "title": "Double-blind comparison of the two hallucinogens psilocybin and dextromethorphan: effects on cognition.", "authors": "Barrett FS, Carbonaro TM, Hurwitz E, Johnson MW, Griffiths RR", "journal": "Psychopharmacology", "publication_date": "2018-10-01", "publication_year": 2018, "doi": "10.1007/s00213-018-4981-x", "pubmed_id": "30062577", "openalex_id": "https://openalex.org/W2886435130", "source_url": "https://pubmed.ncbi.nlm.nih.gov/30062577/", "substance_tags": "psilocybin", "topic_tags": "Pharmacology,Receptor Pharmacology", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:25", "bibtex": null, "source_record_id": "PMID:30062577", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/30062577/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:30062577", "source_url": "https://pubmed.ncbi.nlm.nih.gov/30062577/", "doi": "10.1007/s00213-018-4981-x", "pmid": "30062577", "publication_date": "2018-10-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2402, "title": "Psychedelic therapy for smoking cessation: Qualitative analysis of participant accounts.", "authors": "Noorani T, Garcia-Romeu A, Swift TC, Griffiths RR, Johnson MW", "journal": "Journal of psychopharmacology (Oxford, England)", "publication_date": "2018-07-01", "publication_year": 2018, "doi": "10.1177/0269881118780612", "pubmed_id": "29938565", "openalex_id": "https://openalex.org/W2809850625", "source_url": "https://pubmed.ncbi.nlm.nih.gov/29938565/", "substance_tags": "psilocybin", "topic_tags": "Addiction,Mechanism of Action", "study_type": "Qualitative Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:25", "bibtex": null, "source_record_id": "PMID:29938565", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/29938565/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:29938565", "source_url": "https://pubmed.ncbi.nlm.nih.gov/29938565/", "doi": "10.1177/0269881118780612", "pmid": "29938565", "publication_date": "2018-07-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5162, "title": "T263. Psilocybin Improves Cognitive Control and Downregulates Parietal Cortex in Treatment-Seeking Smokers", "authors": "Michael C. McKenna, John R. Fedota, Albert Garcia-Romeu, Matthew R. Johnson, Roland R. Griffiths, Elliot A. Stein", "journal": "Biological Psychiatry", "publication_date": "2018-04-08", "publication_year": 2018, "doi": "10.1016/j.biopsych.2018.02.600", "pubmed_id": null, "openalex_id": "https://openalex.org/W2797159874", "source_url": "https://doi.org/10.1016/j.biopsych.2018.02.600", "substance_tags": "psilocybin", "topic_tags": "Addiction,Receptor Pharmacology", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:52:02", "last_checked": "2026-07-04 07:00:40", "bibtex": null, "source_record_id": "DOI:10.1016/j.biopsych.2018.02.600", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.biopsych.2018.02.600", "source_url": "https://doi.org/10.1016/j.biopsych.2018.02.600", "doi": "10.1016/j.biopsych.2018.02.600", "pmid": "", "publication_date": "2018-04-08", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2428, "title": "Double-blind comparison of the two hallucinogens psilocybin and dextromethorphan: similarities and differences in subjective experiences.", "authors": "Carbonaro TM, Johnson MW, Hurwitz E, Griffiths RR", "journal": "Psychopharmacology", "publication_date": "2018-02-01", "publication_year": 2018, "doi": "10.1007/s00213-017-4769-4", "pubmed_id": "29116367", "openalex_id": "https://openalex.org/W2767725891", "source_url": "https://pubmed.ncbi.nlm.nih.gov/29116367/", "substance_tags": "psilocybin", "topic_tags": "Mechanism of Action,Receptor Pharmacology,Mystical Experience,Healthy Volunteers", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:26", "bibtex": null, "source_record_id": "PMID:29116367", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/29116367/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:29116367", "source_url": "https://pubmed.ncbi.nlm.nih.gov/29116367/", "doi": "10.1007/s00213-017-4769-4", "pmid": "29116367", "publication_date": "2018-02-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2442, "title": "Classic Hallucinogens and Mystical Experiences: Phenomenology and Neural Correlates.", "authors": "Barrett FS, Griffiths RR", "journal": "Current topics in behavioral neurosciences", "publication_date": "2018-01-01", "publication_year": 2018, "doi": "10.1007/7854_2017_474", "pubmed_id": "28401522", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/28401522/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Default Mode Network,Mystical Experience,Review Article,Healthy Volunteers", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:26", "bibtex": null, "source_record_id": "PMID:28401522", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/28401522/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:28401522", "source_url": "https://pubmed.ncbi.nlm.nih.gov/28401522/", "doi": "10.1007/7854_2017_474", "pmid": "28401522", "publication_date": "2018-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2438, "title": "Psilocybin-occasioned mystical-type experience in combination with meditation and other spiritual practices produces enduring positive changes in psychological functioning and in trait measures of prosocial attitudes and behaviors.", "authors": "Griffiths RR, Johnson MW, Richards WA, Richards BD, Jesse R, MacLean KA, Barrett FS, Cosimano MP, Klinedinst MA", "journal": "Journal of psychopharmacology (Oxford, England)", "publication_date": "2018-01-01", "publication_year": 2018, "doi": "10.1177/0269881117731279", "pubmed_id": "29020861", "openalex_id": "https://openalex.org/W2762822955", "source_url": "https://pubmed.ncbi.nlm.nih.gov/29020861/", "substance_tags": "psilocybin", "topic_tags": "Wellbeing,Spirituality,Mystical Experience,Healthy Volunteers", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:26", "bibtex": null, "source_record_id": "PMID:29020861", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/29020861/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:29020861", "source_url": "https://pubmed.ncbi.nlm.nih.gov/29020861/", "doi": "10.1177/0269881117731279", "pmid": "29020861", "publication_date": "2018-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2369, "title": "Intensity of Mystical Experiences Occasioned by 5-MeO-DMT and Comparison With a Prior Psilocybin Study.", "authors": "Barsuglia J, Davis AK, Palmer R, Lancelotta R, Windham-Herman AM, Peterson K, Polanco M, Grant R, Griffiths RR", "journal": "Frontiers in psychology", "publication_date": "2018-01-01", "publication_year": 2018, "doi": "10.3389/fpsyg.2018.02459", "pubmed_id": "30574112", "openalex_id": "https://openalex.org/W2904505693", "source_url": "https://pubmed.ncbi.nlm.nih.gov/30574112/", "substance_tags": "psilocybin", "topic_tags": "Spirituality,Mystical Experience", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:25", "bibtex": null, "source_record_id": "PMID:30574112", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/30574112/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:30574112", "source_url": "https://pubmed.ncbi.nlm.nih.gov/30574112/", "doi": "10.3389/fpsyg.2018.02459", "pmid": "30574112", "publication_date": "2018-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2451, "title": "Neuroticism is associated with challenging experiences with psilocybin mushrooms.", "authors": "Barrett FS, Johnson MW, Griffiths RR", "journal": "Personality and individual differences", "publication_date": "2017-10-15", "publication_year": 2017, "doi": "10.1016/j.paid.2017.06.004", "pubmed_id": "28781400", "openalex_id": "https://openalex.org/W2623228771", "source_url": "https://pubmed.ncbi.nlm.nih.gov/28781400/", "substance_tags": "psilocybin", "topic_tags": "Personality Change,Emotional Processing,Observational Study", "study_type": "Observational Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:26", "bibtex": null, "source_record_id": "PMID:28781400", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/28781400/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:28781400", "source_url": "https://pubmed.ncbi.nlm.nih.gov/28781400/", "doi": "10.1016/j.paid.2017.06.004", "pmid": "28781400", "publication_date": "2017-10-15", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2468, "title": "An online survey of tobacco smoking cessation associated with naturalistic psychedelic use.", "authors": "Johnson MW, Garcia-Romeu A, Johnson PS, Griffiths RR", "journal": "Journal of psychopharmacology (Oxford, England)", "publication_date": "2017-07-01", "publication_year": 2017, "doi": "10.1177/0269881116684335", "pubmed_id": "28095732", "openalex_id": "https://openalex.org/W2573408014", "source_url": "https://pubmed.ncbi.nlm.nih.gov/28095732/", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Mechanism of Action,Emotional Processing,Spirituality,Mystical Experience,Observational Study", "study_type": "Observational Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:26", "bibtex": null, "source_record_id": "PMID:28095732", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/28095732/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:28095732", "source_url": "https://pubmed.ncbi.nlm.nih.gov/28095732/", "doi": "10.1177/0269881116684335", "pmid": "28095732", "publication_date": "2017-07-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2467, "title": "Potential Therapeutic Effects of Psilocybin.", "authors": "Johnson MW, Griffiths RR", "journal": "Neurotherapeutics: the journal of the American Society for Experimental NeuroTherapeutics", "publication_date": "2017-07-01", "publication_year": 2017, "doi": "10.1007/s13311-017-0542-y", "pubmed_id": "28585222", "openalex_id": "https://openalex.org/W2622982732", "source_url": "https://pubmed.ncbi.nlm.nih.gov/28585222/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Mechanism of Action,Review Article,Cancer Patients,Treatment-Resistant Depression,Safety", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:26", "bibtex": null, "source_record_id": "PMID:28585222", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/28585222/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:28585222", "source_url": "https://pubmed.ncbi.nlm.nih.gov/28585222/", "doi": "10.1007/s13311-017-0542-y", "pmid": "28585222", "publication_date": "2017-07-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5212, "title": "Comparison of anomalous experiences after ingesting psilocybin mushrooms in research and non-research settings", "authors": "Theresa M. Carbonaro, Matthew W. Johnson, Roland R. Griffiths", "journal": "Drug and Alcohol Dependence", "publication_date": "2017-01-21", "publication_year": 2017, "doi": "10.1016/j.drugalcdep.2016.08.107", "pubmed_id": null, "openalex_id": "https://openalex.org/W2578015169", "source_url": "https://doi.org/10.1016/j.drugalcdep.2016.08.107", "substance_tags": "psilocybin", "topic_tags": "General", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:52:03", "last_checked": "2026-08-09 08:25:52", "bibtex": null, "source_record_id": "DOI:10.1016/j.drugalcdep.2016.08.107", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.drugalcdep.2016.08.107", "source_url": "https://doi.org/10.1016/j.drugalcdep.2016.08.107", "doi": "10.1016/j.drugalcdep.2016.08.107", "pmid": "", "publication_date": "2017-01-21", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5211, "title": "Psilocybin in long-term meditators: Effects on default mode network functional connectivity and retrospective ratings of qualitative experience", "authors": "Frederick S. Barrett, Matthew W. Johnson, Roland R. Griffiths", "journal": "Drug and Alcohol Dependence", "publication_date": "2017-01-21", "publication_year": 2017, "doi": "10.1016/j.drugalcdep.2016.08.058", "pubmed_id": null, "openalex_id": "https://openalex.org/W2577870460", "source_url": "https://doi.org/10.1016/j.drugalcdep.2016.08.058", "substance_tags": "psilocybin", "topic_tags": "Addiction,Default Mode Network,Randomized Controlled Trial", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:52:03", "last_checked": "2026-08-09 08:25:52", "bibtex": null, "source_record_id": "DOI:10.1016/j.drugalcdep.2016.08.058", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.drugalcdep.2016.08.058", "source_url": "https://doi.org/10.1016/j.drugalcdep.2016.08.058", "doi": "10.1016/j.drugalcdep.2016.08.058", "pmid": "", "publication_date": "2017-01-21", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2485, "title": "Long-term follow-up of psilocybin-facilitated smoking cessation.", "authors": "Johnson MW, Garcia-Romeu A, Griffiths RR", "journal": "The American journal of drug and alcohol abuse", "publication_date": "2017-01-01", "publication_year": 2017, "doi": "10.3109/00952990.2016.1170135", "pubmed_id": "27441452", "openalex_id": "https://openalex.org/W2506717582", "source_url": "https://pubmed.ncbi.nlm.nih.gov/27441452/", "substance_tags": "psilocybin", "topic_tags": "Addiction,Receptor Pharmacology,Spirituality,Mystical Experience", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:27", "bibtex": null, "source_record_id": "PMID:27441452", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/27441452/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:27441452", "source_url": "https://pubmed.ncbi.nlm.nih.gov/27441452/", "doi": "10.3109/00952990.2016.1170135", "pmid": "27441452", "publication_date": "2017-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2464, "title": "Qualitative and Quantitative Features of Music Reported to Support Peak Mystical Experiences during Psychedelic Therapy Sessions.", "authors": "Barrett FS, Robbins H, Smooke D, Brown JL, Griffiths RR", "journal": "Frontiers in psychology", "publication_date": "2017-01-01", "publication_year": 2017, "doi": "10.3389/fpsyg.2017.01238", "pubmed_id": "28790944", "openalex_id": "https://openalex.org/W2738683289", "source_url": "https://pubmed.ncbi.nlm.nih.gov/28790944/", "substance_tags": "psilocybin", "topic_tags": "Mystical Experience,Clinical Trial,Observational Study", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:26", "bibtex": null, "source_record_id": "PMID:28790944", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/28790944/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:28790944", "source_url": "https://pubmed.ncbi.nlm.nih.gov/28790944/", "doi": "10.3389/fpsyg.2017.01238", "pmid": "28790944", "publication_date": "2017-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2500, "title": "Survey study of challenging experiences after ingesting psilocybin mushrooms: Acute and enduring positive and negative consequences.", "authors": "Carbonaro TM, Bradstreet MP, Barrett FS, MacLean KA, Jesse R, Johnson MW, Griffiths RR", "journal": "Journal of psychopharmacology (Oxford, England)", "publication_date": "2016-12-01", "publication_year": 2016, "doi": "10.1177/0269881116662634", "pubmed_id": "27578767", "openalex_id": "https://openalex.org/W2513336695", "source_url": "https://pubmed.ncbi.nlm.nih.gov/27578767/", "substance_tags": "psilocybin", "topic_tags": "Wellbeing,Observational Study,Safety", "study_type": "Observational Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:27", "bibtex": null, "source_record_id": "PMID:27578767", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/27578767/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:27578767", "source_url": "https://pubmed.ncbi.nlm.nih.gov/27578767/", "doi": "10.1177/0269881116662634", "pmid": "27578767", "publication_date": "2016-12-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2498, "title": "The Challenging Experience Questionnaire: Characterization of challenging experiences with psilocybin mushrooms.", "authors": "Barrett FS, Bradstreet MP, Leoutsakos JS, Johnson MW, Griffiths RR", "journal": "Journal of psychopharmacology (Oxford, England)", "publication_date": "2016-12-01", "publication_year": 2016, "doi": "10.1177/0269881116678781", "pubmed_id": "27856683", "openalex_id": "https://openalex.org/W2549202270", "source_url": "https://pubmed.ncbi.nlm.nih.gov/27856683/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Consciousness,Wellbeing,Spirituality,Case Report,Observational Study,Safety", "study_type": "Case Report", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:27", "bibtex": null, "source_record_id": "PMID:27856683", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/27856683/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:27856683", "source_url": "https://pubmed.ncbi.nlm.nih.gov/27856683/", "doi": "10.1177/0269881116678781", "pmid": "27856683", "publication_date": "2016-12-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2494, "title": "Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial.", "authors": "Griffiths RR, Johnson MW, Carducci MA, Umbricht A, Richards WA, Richards BD, Cosimano MP, Klinedinst MA", "journal": "Journal of psychopharmacology (Oxford, England)", "publication_date": "2016-12-01", "publication_year": 2016, "doi": "10.1177/0269881116675513", "pubmed_id": "27909165", "openalex_id": "https://openalex.org/W2558412547", "source_url": "https://pubmed.ncbi.nlm.nih.gov/27909165/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Wellbeing,Spirituality,Mystical Experience,Cancer Patients,Healthcare Workers", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:27", "bibtex": null, "source_record_id": "PMID:27909165", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/27909165/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:27909165", "source_url": "https://pubmed.ncbi.nlm.nih.gov/27909165/", "doi": "10.1177/0269881116675513", "pmid": "27909165", "publication_date": "2016-12-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2507, "title": "Naltrexone but Not Ketanserin Antagonizes the Subjective, Cardiovascular, and Neuroendocrine Effects of Salvinorin-A in Humans.", "authors": "Maqueda AE, Valle M, Addy PH, Antonijoan RM, Puntes M, Coimbra J, Ballester MR, Garrido M, González M, Claramunt J, Barker S, Lomnicka I, Waguespack M, Johnson MW, Griffiths RR, Riba J", "journal": "The international journal of neuropsychopharmacology", "publication_date": "2016-07-01", "publication_year": 2016, "doi": "10.1093/ijnp/pyw016", "pubmed_id": "26874330", "openalex_id": "https://openalex.org/W2299277295", "source_url": "https://pubmed.ncbi.nlm.nih.gov/26874330/", "substance_tags": "psilocybin", "topic_tags": "Addiction,Pharmacology,Mechanism of Action,Receptor Pharmacology,Healthy Volunteers", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:27", "bibtex": null, "source_record_id": "PMID:26874330", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/26874330/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:26874330", "source_url": "https://pubmed.ncbi.nlm.nih.gov/26874330/", "doi": "10.1093/ijnp/pyw016", "pmid": "26874330", "publication_date": "2016-07-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5258, "title": "Long-term follow-up of psilocybin-facilitated smoking cessation: Abstinence outcomes and qualitative analysis of participant accounts", "authors": "Albert Garcia-Romeu, Tehseen Noorani, Roland R. Griffiths, Matthew W. Johnson", "journal": "Drug and Alcohol Dependence", "publication_date": "2015-11-01", "publication_year": 2015, "doi": "10.1016/j.drugalcdep.2015.07.1130", "pubmed_id": null, "openalex_id": "https://openalex.org/W2470759954", "source_url": "https://doi.org/10.1016/j.drugalcdep.2015.07.1130", "substance_tags": "psilocybin", "topic_tags": "Addiction,Receptor Pharmacology", "study_type": "Qualitative Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:52:03", "last_checked": "2026-08-09 08:25:53", "bibtex": null, "source_record_id": "DOI:10.1016/j.drugalcdep.2015.07.1130", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.drugalcdep.2015.07.1130", "source_url": "https://doi.org/10.1016/j.drugalcdep.2015.07.1130", "doi": "10.1016/j.drugalcdep.2015.07.1130", "pmid": "", "publication_date": "2015-11-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5257, "title": "Validation of the revised mystical experiences questionnaire in experimental sessions with psilocybin", "authors": "Frederick S. Barrett, Matthew W. Johnson, Roland R. Griffiths", "journal": "Drug and Alcohol Dependence", "publication_date": "2015-11-01", "publication_year": 2015, "doi": "10.1016/j.drugalcdep.2015.07.961", "pubmed_id": null, "openalex_id": "https://openalex.org/W2218541786", "source_url": "https://doi.org/10.1016/j.drugalcdep.2015.07.961", "substance_tags": "psilocybin", "topic_tags": "Mystical Experience", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:52:03", "last_checked": "2026-08-09 08:25:53", "bibtex": null, "source_record_id": "DOI:10.1016/j.drugalcdep.2015.07.961", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.drugalcdep.2015.07.961", "source_url": "https://doi.org/10.1016/j.drugalcdep.2015.07.961", "doi": "10.1016/j.drugalcdep.2015.07.961", "pmid": "", "publication_date": "2015-11-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2528, "title": "Validation of the revised Mystical Experience Questionnaire in experimental sessions with psilocybin.", "authors": "Barrett FS, Johnson MW, Griffiths RR", "journal": "Journal of psychopharmacology (Oxford, England)", "publication_date": "2015-11-01", "publication_year": 2015, "doi": "10.1177/0269881115609019", "pubmed_id": "26442957", "openalex_id": "https://openalex.org/W2340085151", "source_url": "https://pubmed.ncbi.nlm.nih.gov/26442957/", "substance_tags": "psilocybin", "topic_tags": "Wellbeing,Spirituality,Mystical Experience,Observational Study", "study_type": "Observational Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:27", "bibtex": null, "source_record_id": "PMID:26442957", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/26442957/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:26442957", "source_url": "https://pubmed.ncbi.nlm.nih.gov/26442957/", "doi": "10.1177/0269881115609019", "pmid": "26442957", "publication_date": "2015-11-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5260, "title": "Comparative phenomenology of psilocybin experiences in research and non-research settings", "authors": "Theresa M. Carbonaro, Margaret A. Klinedinst, Matthew W. Johnson, Roland R. Griffiths", "journal": "Drug and Alcohol Dependence", "publication_date": "2015-10-31", "publication_year": 2015, "doi": "10.1016/j.drugalcdep.2015.07.1017", "pubmed_id": null, "openalex_id": "https://openalex.org/W2346012242", "source_url": "https://doi.org/10.1016/j.drugalcdep.2015.07.1017", "substance_tags": "psilocybin", "topic_tags": "General", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:52:03", "last_checked": "2026-08-09 08:25:53", "bibtex": null, "source_record_id": "DOI:10.1016/j.drugalcdep.2015.07.1017", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.drugalcdep.2015.07.1017", "source_url": "https://doi.org/10.1016/j.drugalcdep.2015.07.1017", "doi": "10.1016/j.drugalcdep.2015.07.1017", "pmid": "", "publication_date": "2015-10-31", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2534, "title": "Psilocybin, psychological distress, and suicidality.", "authors": "Hendricks PS, Johnson MW, Griffiths RR", "journal": "Journal of psychopharmacology (Oxford, England)", "publication_date": "2015-09-01", "publication_year": 2015, "doi": "10.1177/0269881115598338", "pubmed_id": "26395582", "openalex_id": "https://openalex.org/W2130119797", "source_url": "https://pubmed.ncbi.nlm.nih.gov/26395582/", "substance_tags": "psilocybin", "topic_tags": "General", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:27", "bibtex": null, "source_record_id": "PMID:26395582", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/26395582/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:26395582", "source_url": "https://pubmed.ncbi.nlm.nih.gov/26395582/", "doi": "10.1177/0269881115598338", "pmid": "26395582", "publication_date": "2015-09-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5282, "title": "Survey study of challenging experiences after ingesting psilocybin mushrooms: Demographics and phenomenology", "authors": "Theresa M. Carbonaro, Frederick S. Barrett, Matthew P. Bradstreet, Matthew W. Johnson, Katherine A. MacLean, Robert L. Jesse, Roland R. Griffiths", "journal": "Drug and Alcohol Dependence", "publication_date": "2014-12-16", "publication_year": 2014, "doi": "10.1016/j.drugalcdep.2014.09.118", "pubmed_id": null, "openalex_id": "https://openalex.org/W2317303115", "source_url": "https://doi.org/10.1016/j.drugalcdep.2014.09.118", "substance_tags": "psilocybin", "topic_tags": "Pharmacology,Observational Study,Toxicity", "study_type": "Observational Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:52:04", "last_checked": "2026-08-09 08:25:53", "bibtex": null, "source_record_id": "DOI:10.1016/j.drugalcdep.2014.09.118", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.drugalcdep.2014.09.118", "source_url": "https://doi.org/10.1016/j.drugalcdep.2014.09.118", "doi": "10.1016/j.drugalcdep.2014.09.118", "pmid": "", "publication_date": "2014-12-16", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5281, "title": "The challenging experience questionnaire: Characterization of acute adverse reactions to psilocybin", "authors": "Frederick S. Barrett, Matthew P. Bradstreet, Jeannie-Marie Leoutsakos, Matthew W. Johnson, Katherine A. MacLean, Robert L. Jesse, Roland R. Griffiths", "journal": "Drug and Alcohol Dependence", "publication_date": "2014-12-16", "publication_year": 2014, "doi": "10.1016/j.drugalcdep.2014.09.060", "pubmed_id": null, "openalex_id": "https://openalex.org/W2326208220", "source_url": "https://doi.org/10.1016/j.drugalcdep.2014.09.060", "substance_tags": "psilocybin", "topic_tags": "Pharmacology", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:52:04", "last_checked": "2026-08-09 08:25:53", "bibtex": null, "source_record_id": "DOI:10.1016/j.drugalcdep.2014.09.060", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.drugalcdep.2014.09.060", "source_url": "https://doi.org/10.1016/j.drugalcdep.2014.09.060", "doi": "10.1016/j.drugalcdep.2014.09.060", "pmid": "", "publication_date": "2014-12-16", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2555, "title": "Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction.", "authors": "Johnson MW, Garcia-Romeu A, Cosimano MP, Griffiths RR", "journal": "Journal of psychopharmacology (Oxford, England)", "publication_date": "2014-11-01", "publication_year": 2014, "doi": "10.1177/0269881114548296", "pubmed_id": "25213996", "openalex_id": "https://openalex.org/W2122459973", "source_url": "https://pubmed.ncbi.nlm.nih.gov/25213996/", "substance_tags": "psilocybin", "topic_tags": "Addiction,Receptor Pharmacology,Biomarkers,Safety", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:27", "bibtex": null, "source_record_id": "PMID:25213996", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/25213996/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:25213996", "source_url": "https://pubmed.ncbi.nlm.nih.gov/25213996/", "doi": "10.1177/0269881114548296", "pmid": "25213996", "publication_date": "2014-11-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5293, "title": "Characterization of challenging experiences (i.e., bad trips) after ingesting psilocybin", "authors": "Matthew P. Bradstreet, Matthew W. Johnson, Katherine A. MacLean, Roland R. Griffiths", "journal": "Drug and Alcohol Dependence", "publication_date": "2014-06-07", "publication_year": 2014, "doi": "10.1016/j.drugalcdep.2014.02.072", "pubmed_id": null, "openalex_id": "https://openalex.org/W1998044228", "source_url": "https://doi.org/10.1016/j.drugalcdep.2014.02.072", "substance_tags": "psilocybin", "topic_tags": "General", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:52:04", "last_checked": "2026-08-09 08:25:53", "bibtex": null, "source_record_id": "DOI:10.1016/j.drugalcdep.2014.02.072", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.drugalcdep.2014.02.072", "source_url": "https://doi.org/10.1016/j.drugalcdep.2014.02.072", "doi": "10.1016/j.drugalcdep.2014.02.072", "pmid": "", "publication_date": "2014-06-07", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5292, "title": "Examining the psychological mechanisms of psilocybin-assisted smoking cessation treatment: A pilot study", "authors": "Albert Garcia-Romeu, Matthew W. Johnson, Roland R. Griffiths", "journal": "Drug and Alcohol Dependence", "publication_date": "2014-06-07", "publication_year": 2014, "doi": "10.1016/j.drugalcdep.2014.02.200", "pubmed_id": null, "openalex_id": "https://openalex.org/W2111139037", "source_url": "https://doi.org/10.1016/j.drugalcdep.2014.02.200", "substance_tags": "psilocybin", "topic_tags": "Addiction,Mechanism of Action,Randomized Controlled Trial", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:52:04", "last_checked": "2026-08-09 08:25:53", "bibtex": null, "source_record_id": "DOI:10.1016/j.drugalcdep.2014.02.200", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.drugalcdep.2014.02.200", "source_url": "https://doi.org/10.1016/j.drugalcdep.2014.02.200", "doi": "10.1016/j.drugalcdep.2014.02.200", "pmid": "", "publication_date": "2014-06-07", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5300, "title": "PSILOCYBIN RESEARCH AT JOHNS HOPKINS: A 2014 REPORT", "authors": "Robert L. Jesse, Roland R. Griffiths", "journal": "Council on Spiritual Practices", "publication_date": "2014-01-01", "publication_year": 2014, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W2551216332", "source_url": "http://csp.org/HopkinsPsilocybin2014.pdf", "substance_tags": "psilocybin", "topic_tags": "Addiction,Wellbeing,Spirituality,Mystical Experience,Observational Study,Cancer Patients,Safety", "study_type": "Observational Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:52:04", "last_checked": "2026-08-09 09:00:16", "bibtex": null, "source_record_id": "http://csp.org/HopkinsPsilocybin2014.pdf", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://csp.org/HopkinsPsilocybin2014.pdf", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "http://csp.org/HopkinsPsilocybin2014.pdf", "source_url": "http://csp.org/HopkinsPsilocybin2014.pdf", "doi": "", "pmid": "", "publication_date": "2014-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2566, "title": "Psilocybin-occasioned mystical experiences in the treatment of tobacco addiction.", "authors": "Garcia-Romeu A, Griffiths RR, Johnson MW", "journal": "Current drug abuse reviews", "publication_date": "2014-01-01", "publication_year": 2014, "doi": "10.2174/1874473708666150107121331", "pubmed_id": "25563443", "openalex_id": "https://openalex.org/W2140013897", "source_url": "https://pubmed.ncbi.nlm.nih.gov/25563443/", "substance_tags": "psilocybin", "topic_tags": "Addiction,Personality Change,Spirituality,Mystical Experience,Healthy Volunteers", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:28", "bibtex": null, "source_record_id": "PMID:25563443", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/25563443/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:25563443", "source_url": "https://pubmed.ncbi.nlm.nih.gov/25563443/", "doi": "10.2174/1874473708666150107121331", "pmid": "25563443", "publication_date": "2014-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2596, "title": "Factor Analysis of the Mystical Experience Questionnaire: A Study of Experiences Occasioned by the Hallucinogen Psilocybin.", "authors": "Maclean KA, Leoutsakos JM, Johnson MW, Griffiths RR", "journal": "Journal for the scientific study of religion", "publication_date": "2012-12-01", "publication_year": 2012, "doi": "10.1111/j.1468-5906.2012.01685.x", "pubmed_id": "23316089", "openalex_id": "https://openalex.org/W2024490100", "source_url": "https://pubmed.ncbi.nlm.nih.gov/23316089/", "substance_tags": "psilocybin", "topic_tags": "Spirituality,Mystical Experience", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:28", "bibtex": null, "source_record_id": "PMID:23316089", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/23316089/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:23316089", "source_url": "https://pubmed.ncbi.nlm.nih.gov/23316089/", "doi": "10.1111/j.1468-5906.2012.01685.x", "pmid": "23316089", "publication_date": "2012-12-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2601, "title": "High doses of dextromethorphan, an NMDA antagonist, produce effects similar to classic hallucinogens.", "authors": "Reissig CJ, Carter LP, Johnson MW, Mintzer MZ, Klinedinst MA, Griffiths RR", "journal": "Psychopharmacology", "publication_date": "2012-09-01", "publication_year": 2012, "doi": "10.1007/s00213-012-2680-6", "pubmed_id": "22526529", "openalex_id": "https://openalex.org/W2043678991", "source_url": "https://pubmed.ncbi.nlm.nih.gov/22526529/", "substance_tags": "psilocybin", "topic_tags": "Anxiety,Headache / Migraine,Spirituality,Mystical Experience,Healthy Volunteers", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:28", "bibtex": null, "source_record_id": "PMID:22526529", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/22526529/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:22526529", "source_url": "https://pubmed.ncbi.nlm.nih.gov/22526529/", "doi": "10.1007/s00213-012-2680-6", "pmid": "22526529", "publication_date": "2012-09-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2604, "title": "Psilocybin dose-dependently causes delayed, transient headaches in healthy volunteers.", "authors": "Johnson MW, Sewell RA, Griffiths RR", "journal": "Drug and alcohol dependence", "publication_date": "2012-06-01", "publication_year": 2012, "doi": "10.1016/j.drugalcdep.2011.10.029", "pubmed_id": "22129843", "openalex_id": "https://openalex.org/W2022443784", "source_url": "https://pubmed.ncbi.nlm.nih.gov/22129843/", "substance_tags": "psilocybin", "topic_tags": "Headache / Migraine,Mechanism of Action,Healthy Volunteers,Adverse Events", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:28", "bibtex": null, "source_record_id": "PMID:22129843", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/22129843/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:22129843", "source_url": "https://pubmed.ncbi.nlm.nih.gov/22129843/", "doi": "10.1016/j.drugalcdep.2011.10.029", "pmid": "22129843", "publication_date": "2012-06-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2611, "title": "Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects.", "authors": "Griffiths RR, Johnson MW, Richards WA, Richards BD, McCann U, Jesse R", "journal": "Psychopharmacology", "publication_date": "2011-12-01", "publication_year": 2011, "doi": "10.1007/s00213-011-2358-5", "pubmed_id": "21674151", "openalex_id": "https://openalex.org/W2001101493", "source_url": "https://pubmed.ncbi.nlm.nih.gov/21674151/", "substance_tags": "psilocybin", "topic_tags": "Anxiety,Spirituality,Mystical Experience", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:28", "bibtex": null, "source_record_id": "PMID:21674151", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/21674151/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:21674151", "source_url": "https://pubmed.ncbi.nlm.nih.gov/21674151/", "doi": "10.1007/s00213-011-2358-5", "pmid": "21674151", "publication_date": "2011-12-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2612, "title": "Mystical experiences occasioned by the hallucinogen psilocybin lead to increases in the personality domain of openness.", "authors": "MacLean KA, Johnson MW, Griffiths RR", "journal": "Journal of psychopharmacology (Oxford, England)", "publication_date": "2011-11-01", "publication_year": 2011, "doi": "10.1177/0269881111420188", "pubmed_id": "21956378", "openalex_id": "https://openalex.org/W2118739111", "source_url": "https://pubmed.ncbi.nlm.nih.gov/21956378/", "substance_tags": "psilocybin", "topic_tags": "Personality Change,Creativity,Spirituality,Mystical Experience", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:28", "bibtex": null, "source_record_id": "PMID:21956378", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/21956378/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:21956378", "source_url": "https://pubmed.ncbi.nlm.nih.gov/21956378/", "doi": "10.1177/0269881111420188", "pmid": "21956378", "publication_date": "2011-11-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2653, "title": "Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later.", "authors": "Griffiths R, Richards W, Johnson M, McCann U, Jesse R", "journal": "Journal of psychopharmacology (Oxford, England)", "publication_date": "2008-08-01", "publication_year": 2008, "doi": "10.1177/0269881108094300", "pubmed_id": "18593735", "openalex_id": "https://openalex.org/W2119738402", "source_url": "https://pubmed.ncbi.nlm.nih.gov/18593735/", "substance_tags": "psilocybin", "topic_tags": "Wellbeing,Personality Change,Spirituality,Mystical Experience", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:29", "bibtex": null, "source_record_id": "PMID:18593735", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/18593735/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:18593735", "source_url": "https://pubmed.ncbi.nlm.nih.gov/18593735/", "doi": "10.1177/0269881108094300", "pmid": "18593735", "publication_date": "2008-08-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2680, "title": "Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance.", "authors": "Griffiths RR, Richards WA, McCann U, Jesse R", "journal": "Psychopharmacology", "publication_date": "2006-08-01", "publication_year": 2006, "doi": "10.1007/s00213-006-0457-5", "pubmed_id": "16826400", "openalex_id": "https://openalex.org/W2121441663", "source_url": "https://pubmed.ncbi.nlm.nih.gov/16826400/", "substance_tags": "psilocybin", "topic_tags": "Anxiety,Spirituality,Mystical Experience", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:29", "bibtex": null, "source_record_id": "PMID:16826400", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/16826400/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:16826400", "source_url": "https://pubmed.ncbi.nlm.nih.gov/16826400/", "doi": "10.1007/s00213-006-0457-5", "pmid": "16826400", "publication_date": "2006-08-01", "importer_version": "2.1.3", "text_redistributed": false } } ] }